Consultant Pharmacist Led- Medicines Optimisation of Older People - - PowerPoint PPT Presentation

Carmel Darcy Consultant Pharmacist (Older People) WHSCT

Consultant Pharmacist Led- Medicines Optimisation of Older People in Northern Ireland 2012 until now.

(Based on data available at the end of December 2017)

Consultant Pharmacists - 2012

Consultant Pharmacist Posts

Project Aim and Objectives

Implement, develop and evaluate

Patient Drug and Healthcare Resource usage Team working

Proposed Model 2012-2014

Core Outcomes

• 453 patients case managed
• 1100 clinical interventions
• 2.5 interventions per patient
• For every 1 drug prescribed 3 drugs were stopped
• £153k pa healthcare resource usage
• >3500 assessed for appropriateness using the

MAI (Medication Appropriateness Index)

• Statistically significant MAI reduction
• Drug cost savings £68K pa

Reproducibility Test 2015-2016

• Intermediate Care - 4.4 clinical interventions
• Care Homes – 2.5-3.6 (range 1 to 10)
• Total MAI significantly dropped from first patient

contact to completion of all pharmacist recommendations.

• Intermediate Care - Total drug cost savings from

primary care was 222k for both Trusts

– Invest to save return is estimated at £2.19 - £3.54 per £1 invested.

• Care Homes - Total drug cost savings from

primary care was 262k for both Trusts

• Invest to save return is estimated at £1.45 per £1 invested.

Medicines Optimisation

• Donaldson report 2014
• Systems, Not Structures 2016
• MOQF 2016

MOOP Regional Roll Out 2017

Trust MOOP Teams Medicines Optimisation for Older People (MOOP) Steering Group NI Regional Innovations in Medicines Group Deliver at LOCAL LEVEL Influence POLICY Trust MOOP Working Group

Consultant Pharmacist-led landscape

Acute Hospital Acute Care @Home IC Care Homes Patients Own Home Adherence Medicines Optimisation for Older People GP Practice Pharmacists Community Pharmacy

Adherence Model 2018

Preliminary findings – typical caseload

• Data have been collected on 59 patients (40 female, 19 male, aged

81.0 ±7.3 years).

• Prior to referral, 33 patients were regarded as completely

independent in managing their medicines.

• 63% of patients were seen by the pharmacist within 7 days
• Case management continued for an average of 25 days (Range = 2

to 65 days).

• 156 clinical interventions were made with 82.7% Eadon self-graded

≥4

• A total of 320 adherence solutions recommended/provided (5.4 per

patient)

• There was a statistically significant reduction in the total number of

drugs taken (p=0.014) and inappropriate prescribing (p<0.001)

• An average drug cost saving of £128.41 per patient per annum has

been realised.

Lessons from the journey

• Develop models of care in line with strategic

direction and policy.

• Engage early with all potential stakeholders.
• Fully understand the system and context you

want to introduce a new service to i.e. process map

• Identify potential service gaps and issues and

then create an action plan in collaboration with all stakeholders

Lessons

• Robustly evaluate with agreed relevant
• utcomes reflective of pharmacy input
• React to data and refine models of care in

response to the evidence

• Disseminate at every opportunity i.e. share

the learning

• Stay consistent with proven care models and

demonstrate reproducibility

Lessons

• Don’t reinvent the wheel but know when to

fix it

• Standardise practice to enable reproducibility

and roll out

• Capture the patient ‘voice’ and service user

experience

Consultant Pharmacist & Patient

General

Practitioner & PBP Community Pharmacist

Hospital Consultant Nursing and AHP

Consultant Pharmacist-Led Models

Clinical Vignette – Intermediate care

• 84 year old female
• PMH: TIA 2007, hypothyroid, Hypertension,

Chronic kidney disease (CKD stage 4)

• Refused package of care.
• Lived with elderly sister.
• PC: Fall – Right hip pain unable to weight bear
• X-ray: No fracture, OA
• Conservative management – transferred to

intermediate care for further rehab.

Medicines on admission

• Atorvastatin 10mg night
• Amlodipine 10mg night
• Bendroflumethiazide 2.5mg morning
• Levothyroxine 50mcg morning
• Folic acid 5mg morning
• Clopidogrel 75mg morning
• Thaimine 100mg three times daily
• Forceval one daily
• Vitamin B co strong
• Paracetamol 1g four times daily
• Omeprazole 20mg twice daily
• Ferrous fumarate 305mg twice daily

NKDA

Polypharmacy 12 medicines 23 doses New New New Dose reduction New New

Pharmaceutical Case management

• Medicines Reconciliation

– On levothyroxine 75mcg mane not 50mcg

• Medicines Review

– Indication/duration/dose – Thiamine, Vitamin B Co, Forceval stopped – Omeprazole stopped – Drug-disease interaction – Bendroflumethiazide stopped (eGFR 34 CrCl 28) – Amlodipine stopped Systolic BP 112mmHg – Paracetamol reduced dose Low BMI/Frailty

Medicines Adherence

• Patient-centred

– Choice and preference considered

• Access

– No car, no telephone – friend/priest

• Day to day management

– ‘never forget to take them’ – Able to pop out of blisters – Good at taking medicines in the morning

• Clinical

– Appropriate medicines – Reduced pill burden (12 to 6 medicines)

Patient’s choice

‘want my medicine boxes back’ ‘want to take them in the morning only’ ‘don’t want them delivered’

Self-administration

• Assessment
• Medicines rationalised
• Medicines reminder

chart

• Nurse - supervised

administration

• Patient – led

‘sister you did it wrong! I begin at the top of the strip and work down’

Continued case management

• Discharged on 6 medicines
• Communicated with GP and CP
• Home visit at 4 weeks
• Compliant with medicines

– ‘liked the medicines reminder chart’ – ‘can I get a few more medicine cups?’

• Would like to only have to organise collection
• f medicines every 3 months

In sum Annie’s journey….

before, during and hopefully NOT after

• Failed to get the right medicines
• Exposed to avoidable risk from her

medicines

• Never given a choice about her

medicines